Follow-up study for certain mitral TEER patients
Part of Heart & circulation clinical trials.
This study checks how well a heart procedure called mitral TEER works over time in real-world patients. It may help doctors confirm safety and performance and improve care for future patients who need the same treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a mitral TEER procedure and were approved for it under the current use instructions, after your Heart Team agreed
- Your procedure was planned (not emergency or done for a non-planned situation)
- You were not in the ICU (intensive care unit) right before your TEER procedure
- You can come to all follow-up visits and complete all required tests
- You are willing to sign a written consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two devices (MitraClip and PASCAL) for repairing a leaky mitral valve (mitral regurgitation). The goal is to see which device works better in a wide range of patients who need this type of repair.
This registry study follows people who are getting a minimally invasive heart valve repair called M-TEER. It helps doctors learn more about how well the procedure works and how patients recover.
This trial tests a less invasive procedure (edge-to-edge mitral valve repair) for people with ATTR-CM and a leaky mitral valve. It aims to see if this repair can help improve symptoms compared to standard medical therapy alone.
This study tests a new catheter-based system to treat severe mitral valve leaking when open-heart surgery is considered high risk. It may help improve blood flow and symptoms by repairing the valve without open surgery, using ultrasound guidance and follow-up visits to track safety and results.
This study looks at how well a newer, less invasive heart valve repair works for people with leaky mitral valves. It aims to create a tool to predict who will get the best results.
This trial tests a new device called the Capstan system to fix a leaky mitral valve (mitral regurgitation) without open-heart surgery. It may help people whose valve leak is moderate to severe and still have symptoms despite medicines.
Hear when a new Mitral Regurgitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.